Willis-Knighton Seeks Participants for Clinical Trials of COVID-19 Treatments,

Willis-Knighton Health System is expanding its clinical trials of monoclonal antibodies for outpatient treatment of people infected with COVID-19., Willis-Knighton Health System is expanding its clinical trials of monoclonal antibodies for outpatient treatment of people infected with COVID-19., Read More

Scroll to Top